With JUSTICE’s agreement to The Company of Biologists’ Read & Publish proposal, we are pleased to introduce a model for promoting open access in the field of biology for Japanese universities. JUSTICE believes in the importance of a healthy ecosystem for the distribution of scholarly information. We hope that the agreement with The Company of Biologists, a non-profit publishing house, will provide an opportunity to expand the diversity within the publication, rather than solely focusing on large commercial publishers.
I value publishing with Development because of their scholarly approach to the editorial process using academic editors. For our most recent paper, I found out that they have a new Read & Publish partnership with Caltech that makes it free for authors to publish and free for everyone else to read our article from day one. Thank you for setting up this great program! Let’s hope many more journals follow suit.
The importance of Open Access for science cannot be emphasized enough, as it increases the accessibility of our research to both the public and institutions without journal subscriptions. My institution has a Read & Publish agreement with The Company of Biologists, and opting for Open Access publication not only incurred no cost in terms of our research funds but was also very easy to apply for in their application system. Such Open Access agreements between journals and institutions are a great step forward towards making science accessible to all – researchers and readers alike.
We at the MPDL are delighted to extend our collaboration with The Company of Biologists, which means we can continue to offer our researchers the possibility to publish open access in all the publisher’s journals as well as access to all previously published content. Providing these opportunities to our authors is at the heart of our overall strategy in the world of scholarly publishing, in line with the Max Planck Society’s vision of openness, which in turn reflects the principles of the OA2020 Initiative and the Berlin Declaration on Open Access.
In our role as the German Information Center for Life Sciences, ZB Med is strongly invested in helping German life scientists publish their work Open Access in an affordable yet highly professional environment. Focusing on Open Access and transformative agreements for German Life Sciences, we invite all interested German academic and research institutions and hospitals to join this consortium agreement with The Company of Biologists to take advantage of this non-APC based, uncapped author publishing opportunity.
I am delighted that the Read & Publish agreement between The Company of Biologists and Goethe University Frankfurt allowed me to publish our latest article in Journal of Cell Science Open Access free of charge. It is extremely important that peer-reviewed scientific results are made freely available as soon as possible and by as many as possible. The entire Open Access process was simple, straightforward, author-friendly and, like the entire publishing process with The Company of Biologists, a thoroughly positive experience.
We are extremely pleased with the recent publication of our article in Biology Open. The APC-free option provided by the Read & Publish agreement between The Company of Biologists and our institution (Northeastern University, Boston) has greatly enhanced presentation of our work and allowed us to channel financial resources directly to continuing the research.
Really delighted about our recent paper in DMM, and was great news that we were able to publish without having to pay an Open Access fee thanks to a Read & Publish agreement with our university.
In 2021, CSIC signed a transformative agreement with The Company of Biologists that supported the publisher’s transition to Read & Publish models. URICI, in its strategy of promoting open access to research outputs, has followed the path of collaborating in this transition with both large publishers and smaller ones, such as The Company of Biologists. In the renewal of this agreement for 2024, the step is taken to also incorporate two fully Open Access journals, since they have been shown to be of great interest among the CSIC’s biology community.
We are glad that corresponding authors from EIFL partner countries will be able to publish Open Access in all The Company of Biologists’ journals. We value the partnership with the Company and welcome the extension of the agreement for three more years for free access and publishing for 30 EIFL partner countries.
Visit our journal websites
